Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

From chaos to clarity? decoding the inflammatory profiles in lower-risk MDS

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSven De PourcqETElena TofacchiMRMarco Gabriele Raddi

Discussion

Loading...

Member takes

Overview

Analysis uncovers distinct inflammatory profiles in lower-risk MDS, suggesting varying responses to erythropoietin stimulating agents.

Key Points

  • Identified five biologically distinct LR-MDS subgroups with unique inflammatory signatures.
  • Random forest models pinpointed key cytokines, including IL-1β and IL-2, as critical discriminators.
  • Principal component analysis and k-means clustering helped explore cytokine relationships and assess responses.
  • Results may guide therapeutic decisions in treating lower-risk MDS, especially concerning ESA response.

Cite This Study

Pourcq et al. (2025) studied this question.

synapsesocial.com/papers/69362f4e4fa91c937236d83ahttps://doi.org/10.1182/blood-2025-3866
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunological biomarkers and TARC/CCL17 in myelodysplastic syndrome: Insights into immune microenvironment regulation2025
  2. 2Real-world patient characteristics, treatment patterns, and outcomes in patients with myelodysplastic syndromes2025
  3. 3Association between lymphocyte-associated ratios, C-reactive protein and prognostic value in myelodysplastic syndromes2025 · 2 citations
  4. 4A prognostic model integrating disease‑ and patient‑oriented factors identifies poor‑outcome patients with low‑risk MDS: A multicenter real‑world cohort study (KOTOSG)2025
  5. 5Bone marrow immune and stromal niche remodeling in myelodysplastic neoplasm patients under erythropoietic therapies by 29-color full-spectrum flow cytometry2025